Neuroalgology Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.
Experimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.
Cells. 2022 Apr 15;11(8):1358. doi: 10.3390/cells11081358.
Axonal degeneration is an active process that differs from neuronal death, and it is the hallmark of many disorders affecting the central and peripheral nervous system. Starting from the analyses of Wallerian degeneration, the simplest experimental model, here we describe how the long projecting neuronal populations affected in Parkinson's disease and chemotherapy-induced peripheral neuropathies share commonalities in the mechanisms and molecular players driving the earliest phase of axon degeneration. Indeed, both dopaminergic and sensory neurons are particularly susceptible to alterations of microtubules and axonal transport as well as to dysfunctions of the ubiquitin proteasome system and protein quality control. Finally, we report an updated review on current knowledge of key molecules able to modulate these targets, blocking the on-going axonal degeneration and inducing neuronal regeneration. These molecules might represent good candidates for disease-modifying treatment, which might expand the window of intervention improving patients' quality of life.
轴突变性是一个主动的过程,与神经元死亡不同,它是许多影响中枢和周围神经系统的疾病的标志。从最简单的实验模型瓦勒氏变性的分析开始,我们在这里描述了帕金森病和化疗诱导的周围神经病中受影响的长投射神经元群体在驱动轴突变性早期阶段的机制和分子参与者方面有何共同之处。事实上,多巴胺能神经元和感觉神经元都特别容易受到微管和轴突运输的改变以及泛素蛋白酶体系统和蛋白质质量控制的功能障碍的影响。最后,我们报告了对能够调节这些靶点的关键分子的最新综述,这些靶点能够阻止正在进行的轴突变性并诱导神经元再生。这些分子可能是疾病修饰治疗的良好候选物,这可能会扩大干预窗口,提高患者的生活质量。